Nurix Therapeutics Inc. (NRIX)
NASDAQ: NRIX
· Real-Time Price · USD
10.57
0.01 (0.09%)
At close: Aug 15, 2025, 3:59 PM
11.00
4.07%
After-hours: Aug 15, 2025, 05:17 PM EDT
Nurix Therapeutics Income Statement
Financials in USD. Fiscal
year is
December - November.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | May 31, 2025 | Feb 28, 2025 | Nov 30, 2024 | Aug 31, 2024 | May 31, 2024 | Feb 29, 2024 | Nov 30, 2023 | Aug 31, 2023 | May 31, 2023 | Feb 28, 2023 | Nov 30, 2022 | Aug 31, 2022 | May 31, 2022 | Feb 28, 2022 | Nov 30, 2021 | Aug 31, 2021 | May 31, 2021 | Feb 28, 2021 |
Revenue | 88.38M | 56.42M | 54.55M | 56.42M | 62.3M | 80.89M | 76.99M | 68.61M | 60.94M | 41.69M | 38.63M | 39.24M | 38.7M | 34.36M | 29.75M | 29.04M | 22.88M | 19.97M |
Cost of Revenue | 8.27M | 12.37M | 12.13M | 15.88M | 15.12M | 14.36M | 13.65M | 12.93M | 12.44M | 11.73M | 10.81M | 8.53M | 36.55M | 59.91M | 80.66M | 100.35M | 88.38M | 76.53M |
Gross Profit | 36.05M | 44.05M | 42.42M | 40.54M | 47.18M | 66.53M | 63.33M | 55.68M | 48.5M | 29.96M | 27.82M | 30.71M | 2.15M | -25.55M | -50.91M | -71.31M | -65.5M | -56.56M |
Operating Income | -230.45M | -230.67M | -213.03M | -193.7M | -179.1M | -157.33M | -155.06M | -158.42M | -165.13M | -184.07M | -183.44M | -172.71M | -154.99M | -135.69M | -117.89M | -99.94M | -90.14M | -76.95M |
Interest Income | 18.37M | 22.45M | 19.73M | 16.99M | 14.28M | 12.69M | 11.12M | 9.71M | 7.69M | 5.51M | 3.51M | 1.83M | 859K | 716K | 823K | 663K | 1.3M | 1.35M |
Pretax Income | -206.47M | -208.22M | -193.3M | -176.71M | -164.82M | -144.64M | -143.95M | -148.71M | -157.44M | -178.56M | -180.36M | -171.3M | -154.55M | -135.39M | -117.06M | -99.28M | -88.84M | -75.6M |
Net Income | -207.32M | -208.4M | -193.57M | -176.98M | -165M | -142.25M | -136.06M | -135.81M | -143.53M | -166.83M | -173.82M | -169.81M | -153.95M | -135.24M | -117.19M | -99.41M | -89.09M | -55.13M |
Selling & General & Admin | 48.37M | 44.04M | 42.34M | 40.58M | 39.48M | 41.21M | 41.08M | 41.49M | 40.61M | 38.59M | 38M | 37.45M | 36.04M | 33.9M | 31.2M | 28.64M | 24.63M | 20.39M |
Research & Development | 270.46M | 238.96M | 217.26M | 197.81M | 190.19M | 189.36M | 187.21M | 185.54M | 185.45M | 187.18M | 184.5M | 174.92M | 158.07M | 136.57M | 116.43M | 100.35M | 88.38M | 76.53M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 318.83M | 283M | 259.6M | 238.39M | 229.67M | 230.57M | 228.29M | 227.03M | 226.06M | 225.77M | 222.49M | 212.37M | 194.11M | 170.47M | 147.64M | 128.98M | 113.01M | 96.92M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | -1.76M | -3.6M | -5.43M | -5.43M | -3.67M | -1.82M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 226.46M | 287.09M | 267.58M | 250.13M | 241.41M | 238.22M | 232.05M | 227.03M | 226.06M | 225.77M | 222.49M | 212.37M | 194.11M | 170.47M | 147.64M | 128.98M | 113.01M | 96.92M |
Income Tax Expense | 850K | 180K | 270K | 262K | 180K | -2.4M | -7.89M | -12.9M | -13.91M | -11.73M | -6.54M | -1.49M | -604K | -151K | 131K | 128K | 251K | -20.48M |
Shares Outstanding (Basic) | 83.88M | 83.56M | 78.41M | 72.78M | 62.38M | 54.9M | 54.67M | 54.39M | 54.26M | 54.03M | 53.94M | 50.87M | 44.9M | 44.69M | 44.55M | 44.37M | 43.8M | 38.78M |
Shares Outstanding (Diluted) | 83.88M | 83.56M | 78.41M | 72.78M | 62.38M | 54.9M | 54.67M | 54.39M | 54.26M | 54.03M | 53.94M | 50.87M | 44.9M | 44.69M | 44.55M | 44.37M | 43.8M | 38.78M |
EPS (Basic) | -2.61 | -2.8 | -2.89 | -2.91 | -2.92 | -2.61 | -2.5 | -2.5 | -2.7 | -3.3 | -3.6 | -3.68 | -3.45 | -3.05 | -2.73 | -2.39 | -2.83 | -2.01 |
EPS (Diluted) | -2.61 | -2.8 | -2.89 | -2.91 | -2.92 | -2.61 | -2.5 | -2.5 | -2.7 | -3.3 | -3.6 | -3.68 | -3.45 | -3.05 | -2.73 | -2.39 | -2.83 | -2.01 |
EBITDA | -217.88M | -214M | -196.6M | -177.82M | -163.99M | -142.97M | -141.41M | -145.49M | -151.68M | -171.02M | -171.74M | -163.28M | -148.71M | -131.58M | -114.97M | -97.14M | -87.53M | -74.62M |
EBIT | -182.13M | -230.67M | -213.03M | -193.7M | -179.1M | -157.33M | -155.06M | -158.42M | -165.13M | -184.07M | -183.87M | -173.13M | -155.41M | -136.11M | -117.89M | -99.94M | -90.14M | -76.95M |
Depreciation & Amortization | 12.58M | 16.67M | 16.43M | 15.88M | 15.12M | 14.36M | 13.65M | 12.93M | 12.44M | 11.73M | 10.81M | 8.53M | 6.34M | 4.31M | 2.7M | 2.59M | 2.44M | 2.33M |